Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(OB: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Performance
Top News
More News
TG Therapeutics, Inc. to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Presentation Scheduled for Tuesday September 27, 2016 at 11:30am ET Read More
from GlobeNewswire News Releases
TG Therapeutics, Inc. Announces Presentation of Data from a Phase Ib Clinical Trial of TG-1101 in Patients with Neuromyelitis Optica (NMO) at the 32nd Congress of the European Committee for Treatment
TG Therapeutics, Inc. (Nasdaq:TGTX) today announced the presentation of data from a Phase Ib open label study of TG-1101 (ublituximab), the Company’s novel, glycoengineered anti-CD20 monoclonal... Read More
from GlobeNewswire News Releases
More News
Read More
TG Therapeutics, Inc. Announces Clinical Data Presentation at the Upcoming 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
from GlobeNewswire News Releases
TG Therapeutics Announces Orphan Drug Designation for TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder
from GlobeNewswire News Releases
TG Therapeutics Announces Orphan Drug Designation for TGR-1202 for Treatment of Chronic Lymphocytic Leukemia
from GlobeNewswire News Releases
TG Therapeutics, Inc. Announces Second Quarter 2016 Financial Results and Business Update
from GlobeNewswire News Releases
Investor Calendar Invites You to the TG Therapeutics, Inc. Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 8, 2016
from Accesswire RSS Master Feed
TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2016 Financial Results and Business Update
from GlobeNewswire News Releases
BRIEF-TG Therapeutics announces orphan drug designation for TG-1101
category companyNews
from Reuters: Company News
BRIEF-TG Therapeutics announces orphan drug designation for TGR-1202 for treatment of chronic lymphocytic leukemia
category companyNews
from Reuters: Company News
Analysts Forecast 13% Gains Ahead For The Holdings of EQWS
category ETFs
from ETF Channel
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here